Correlation Between 456837AV5 and Lipocine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 456837AV5 and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 456837AV5 and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ING GROEP NV and Lipocine, you can compare the effects of market volatilities on 456837AV5 and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 456837AV5 with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of 456837AV5 and Lipocine.

Diversification Opportunities for 456837AV5 and Lipocine

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between 456837AV5 and Lipocine is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding ING GROEP NV and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and 456837AV5 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ING GROEP NV are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of 456837AV5 i.e., 456837AV5 and Lipocine go up and down completely randomly.

Pair Corralation between 456837AV5 and Lipocine

Assuming the 90 days trading horizon 456837AV5 is expected to generate 16.54 times less return on investment than Lipocine. But when comparing it to its historical volatility, ING GROEP NV is 7.78 times less risky than Lipocine. It trades about 0.03 of its potential returns per unit of risk. Lipocine is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  283.00  in Lipocine on September 26, 2024 and sell it today you would earn a total of  207.00  from holding Lipocine or generate 73.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy72.35%
ValuesDaily Returns

ING GROEP NV  vs.  Lipocine

 Performance 
       Timeline  
ING GROEP NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ING GROEP NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 456837AV5 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Lipocine 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, Lipocine may actually be approaching a critical reversion point that can send shares even higher in January 2025.

456837AV5 and Lipocine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 456837AV5 and Lipocine

The main advantage of trading using opposite 456837AV5 and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 456837AV5 position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.
The idea behind ING GROEP NV and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing